Open access
Jul 2026
cfDNA derived gene signatures as surrogate for microvascular invasion in HCC.
A circulating cfDNA-derived 5hmC signature that non-invasively predicts preoperative MVI status, with potential clinical utility in the management of resectable HCC patients is developed and validated.
Ruijie Gong, Linchen Wang, Dondon Xue et al.
· JHEP Reports · 0 citations